Evidence map›Paper›PMID 28124229›Full record

ArticleProtein & cell2017

The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus.

Jian Yang, Huiqiang Yang, Zhushi Li, Hua Lin, Yu Zhao, Wei Wang, Shuai Tan, Xianwu Zeng, Yuhua Li

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Protein & cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jian YangDepartment of Viral Vaccine, Chengdu Institute of Biological Products Co., Ltd., Chengdu, 610023, China.
Huiqiang YangDepartment of Viral Vaccine, Chengdu Institute of Biological Products Co., Ltd., Chengdu, 610023, China.
Zhushi LiDepartment of Viral Vaccine, Chengdu Institute of Biological Products Co., Ltd., Chengdu, 610023, China.
Hua LinDepartment of Viral Vaccine, Chengdu Institute of Biological Products Co., Ltd., Chengdu, 610023, China.
Yu ZhaoDepartment of Viral Vaccine, Chengdu Institute of Biological Products Co., Ltd., Chengdu, 610023, China.
Wei WangDepartment of Viral Vaccine, Chengdu Institute of Biological Products Co., Ltd., Chengdu, 610023, China.
Shuai TanDepartment of Viral Vaccine, Chengdu Institute of Biological Products Co., Ltd., Chengdu, 610023, China.
Xianwu ZengDepartment of Viral Vaccine, Chengdu Institute of Biological Products Co., Ltd., Chengdu, 610023, China.
Yuhua LiDepartment of Arboviruses Vaccine, National Institute for Food and Drug Control, Beijing, 100050, China. liyuhua@nifdc.org.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntibodies, MonoclonalCell LineChlorocebus aethiopsCricetinaeCulicidaeDengue VirusEncephalitis, JapaneseEncephalitis Virus, JapaneseMiceMice, Inbred StrainsVero CellsViral VaccinesAntibodies, MonoclonalViral Vaccines

Identifiers

PMID28124229
PMCPMC5326627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.